Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics.
Ki-Whan ChiSubin SonJusung AnIlwha KimMinhyeok ChoiNa KongWei TaoJong Seung KimPublished in: Chemical Society reviews (2021)
Finding a personalized nano theranostics solution, a nanomedicine for cancer diagnosis and therapy, is among the top challenges of current medicinal science. Porous organic polymers (POPs) are permanent porous organic materials prepared by linking relatively rigid multidimensional organic building blocks. POP nanoparticles have a remarkable advantage for cancer theranostics owing to their specific physicochemical characteristics such as high surface area, convincing pore size engineering, stimuli-responsive degradability, negligible toxicity, open covalent post-synthesis modification possibilities etc. POPs have crystalline and non-crystalline characteristics; crystalline POPs are popularly known as covalent organic frameworks (COFs), and have shown potential application across research areas in science. The early research and development on theranostics applications of nanoscale POPs has shown tremendous future potential for clinical translation. This tutorial review highlights the recently developed promising applications of nPOPs in drug loading, targeted delivery, endogenous and exogenous stimuli-responsive release, cancer imaging and combination therapy, regardless of their crystalline and poorly crystalline properties. The review will provide a platform for the future development and clinical translation of nPOPs by solving fundamental challenges of cancer nanomedicines in drug loading efficiency, size-optimization, biocompatibility, dispersibility and cell uptake ability.
Keyphrases
- papillary thyroid
- combination therapy
- room temperature
- cancer therapy
- drug delivery
- squamous cell
- advanced cancer
- high resolution
- public health
- palliative care
- mass spectrometry
- water soluble
- current status
- squamous cell carcinoma
- lymph node metastasis
- mesenchymal stem cells
- climate change
- human health
- smoking cessation
- drug release
- bone marrow
- young adults